Current Chapter Reviews
Current work plan of chapter reviews:
Each chapter, with the exception of Chapter 5 Infections (antibacterial section), is scheduled for review every two years. Although it is acknowledged that this is often not possible and the review period may be extened.
Changes to a chapter may occasionally become necessary between reviews, for example, when the Drugs and Therapeutics Committee (DTC) approve new therapies, or a drug is withdrawn from supply. These changes will be made, within 3 months of the Joint Formulary Committee agreement, on the web-based version of the formulary.
| Estimated/provisional guide time for review consultation & working group | Chapter | Progress |
| May/June 2011 | Chapter 11, Eye | Review comments with Consultant - Delayed |
| March 2012 (Pain section only) | Chapter 4, Central nervous system (part 2) | Completed |
| April 2012 (Epilepsy section only) | Review with Consultant | |
| September 2012 | Chapter 2, Cardiovascular system | Statins only |
| October/November 2012 | Chapter 12, Ear, nose and oropharynx | Combined review with SDJF |
| October 2012 | Chapter 10, Musculoskeletal and joint diseases | Review comments asked for |
| October/November 2012 | Chapter 5, Infections (antibacterials only) | With Microbiology |
| Chapter 7, Obstetrics, gynaecology and urinary-tract disorders | ||
| Chapter 1, Gastrointestinal system | ||
| Chapter 4, Central nervous system (part 1 Mental Health) | ||
| Chapter 9, Nutrition and blood | ||
| Chapter 3, Respiratory System | ||
| Chapter 14, Immunological products and vaccines | ||
| Chapter 16, Palliative care | ||
| Chapter 6, Endocrine system | ||
| Chapter 13, Skin | ||
| Chapter 5, Infections |
Last updated by: Carol Webb on 01-10-2012 09:53



